MARKET

CRDL

CRDL

Cardiol Therapeu
NASDAQ
1.040
0.000
0.00%
After Hours: 1.080 +0.04 +3.85% 16:45 06/26 EDT
OPEN
1.000
PREV CLOSE
1.040
HIGH
1.060
LOW
1.000
VOLUME
439.80K
TURNOVER
--
52 WEEK HIGH
1.710
52 WEEK LOW
0.8800
MARKET CAP
119.85M
P/E (TTM)
-3.7011
1D
5D
1M
3M
1Y
5Y
1D
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
TipRanks · 2d ago
Cardiol Therapeutics shareholders elect directors at annual meeting
PUBT · 2d ago
Stocks in play: Cardiol Therapeutics Inc.
Barchart · 2d ago
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance
TipRanks · 4d ago
Cardiol Therapeutics announces virtual annual shareholder meeting webcast
PUBT · 4d ago
Stocks in play: Cardiol Therapeutics Inc.
Barchart · 4d ago
Weekly Report: what happened at CRDL last week (0615-0619)?
Weekly Report · 5d ago
Weekly Report: what happened at CRDL last week (0608-0612)?
Weekly Report · 06/15 10:11
More
About CRDL
Cardiol Therapeutics Inc. is a Canada-based clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead small-molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It holds investigational new drug application authorization from the United States Food and Drug Administration (US FDA) to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart: recurrent pericarditis and acute myocarditis. The MAVERIC Program in recurrent pericarditis, an inflammatory disease, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing Phase III MAVERIC trial (NCT06708299). The Company is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure.

Webull offers Cardiol Therapeutics Inc stock information, including NASDAQ: CRDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRDL stock methods without spending real money on the virtual paper trading platform.